barium has been researched along with natriuretic peptide, c-type in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahluwalia, A; Foster, P; Hobbs, A; Prescott, C; Scotland, R | 1 |
| Ahluwalia, A; Hobbs, AJ; Kemp-Harper, B; Madhani, M; Nobles, M; Panayiotou, CM; Scotland, RS; Sheraz, A; Villar, IC | 1 |
2 other study(ies) available for barium and natriuretic peptide, c-type
| Article | Year |
|---|---|
Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
Topics: Acetylcholine; Animals; Atrial Natriuretic Factor; Barium; Coronary Circulation; Drug Evaluation, Preclinical; Endothelium, Vascular; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ouabain; Peptide Fragments; Rats; Rats, Wistar; Receptors, Atrial Natriuretic Factor; Signal Transduction; Vasodilation; Vasodilator Agents | 2004 |
Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.
Topics: Acetylcholine; Animals; Aorta; Atrial Natriuretic Factor; Barium; Biological Factors; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Natriuretic Peptide, C-Type; Oligopeptides; Ouabain; Patch-Clamp Techniques; Potassium Channels; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Potassium-Exchanging ATPase; Spermine; Vasodilation; Vasodilator Agents | 2007 |